Answering a Roya correspondent's question in the Health Ministry press conference Sunday, the Minister of Health Nathir Obeidat said that citizens are not required to know all the results related to the vaccine trials, including for the Chinese Sinopharm vaccine trials. 

He stressed that all the information and details related to the study were made available to the Jordan Food and Drug Administration (JFDA), after the manufacturer sent the results to them.

The JFDA took approximately three weeks to study the trial material before approving the vaccine. The Kingdom previously approved the Pfizer-BioNTech vaccine Dec. 14.

150,000 doses of the Sinopharm vaccine arrived in Jordan Saturday, with Pfizer's doses expected to arrive Monday. 

The Sinopharm vaccine is an inactivated, two-dose vaccine from the Beijing Institute of Biological Products, a subsidiary of the state-owned conglomerate Sinopharm. The company announced Dec. 30 that preliminary data from last-stage trials had shown it to be 79.3 percent effective.

According to Obeidat, the national vaccination program will begin Wednesday in 29 different vaccination centers.